Inipharm is a clinical-stage biopharmaceutical company focused on discovering and developing therapies for severe liver diseases, particularly through small-molecule inhibitors targeting the HSD17B13 protein
Inipharm is a clinical-stage biopharmaceutical company focused on discovering and developing therapies for severe liver diseases, particularly through small-molecule inhibitors targeting the HSD17B13 protein.